A European regulatory committee now recommends approval of the Alzheimer's treatment lecanemab a few months after rejecting ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

Reversing an earlier decision, European regulators recommended that an Alzheimer’s therapy from Eisai and Biogen should be ...

Presented positive interim data for 4D-150 in wet age-related macular degeneration (wet AMD) from PRISM Phase 1/2 clinical trial highlighting ...

Oct 15 (Reuters) - Bayer (BAYGn.DE), opens new tab on Tuesday said it had applied for marketing authorization with the European Medicines Agency (EMA) for its menopause relief drug elinzanetant.

Neurizon Therapeutics Limited (ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company advancing treatments for neurodegenerative diseases, is pleased to announce it has ...

Rolling Submission of NDA for Aficamten Completed and Submitted to FDA in Q3COMET-HF, Confirmatory Phase 3 Clinical Trial of Omecamtiv ...

BERLIN, Oct 14 (Reuters) - Bayer (BAYGn.DE), opens new tab said on Monday that it has applied to the EU's drugs regulator for the use of Nubeqa, also known as darolutamide, in combination with ...

122, Issue. 2, p. 191. Modern languages like English, Spanish, Russian and Hindi as well as ancient languages like Greek, Latin and Sanskrit all belong to the Indo-European language family, which ...

Directive Might Cause Massive Medicine Shortages Affecting Millions Of Patients Across Europe ...